FIRST TRUST ADVISORS LP - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 303 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
FIRST TRUST ADVISORS LP ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$3,606,350
+39.1%
233,119
+41.2%
0.00%
+33.3%
Q2 2023$2,592,982
-61.5%
165,053
-59.6%
0.00%
-62.5%
Q1 2023$6,736,414
+88.7%
408,763
+78.6%
0.01%
+100.0%
Q4 2022$3,569,654
-3.0%
228,824
-19.3%
0.00%
-20.0%
Q3 2022$3,680,000
-20.6%
283,699
-14.1%
0.01%
-16.7%
Q2 2022$4,637,000
-58.9%
330,293
-58.1%
0.01%
-50.0%
Q1 2022$11,284,000
-0.9%
787,958
-5.6%
0.01%
+9.1%
Q4 2021$11,382,000
-63.1%
835,056
-55.6%
0.01%
-66.7%
Q3 2021$30,811,000
+18.5%
1,880,995
+21.8%
0.03%
+17.9%
Q2 2021$25,997,000
-23.5%
1,544,671
-17.0%
0.03%
-31.7%
Q1 2021$33,968,000
+35.7%
1,860,257
+33.2%
0.04%
-4.7%
Q2 2020$25,035,000
+14.5%
1,396,270
-3.0%
0.04%
-14.0%
Q1 2020$21,857,000
-45.4%
1,439,827
-29.0%
0.05%
-26.5%
Q4 2019$40,011,000
+14.0%
2,027,919
-0.6%
0.07%
+3.0%
Q3 2019$35,107,000
+19.8%
2,041,133
+23.3%
0.07%
+20.0%
Q2 2019$29,303,000
-45.2%
1,655,560
-36.9%
0.06%
-48.1%
Q1 2019$53,436,0002,623,2830.11%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2021
NameSharesValueWeighting ↓
Y.D. More Investments Ltd 1,498,811$24,700,3805.57%
TFG Asset Management GP Ltd 1,903,662$31,372,3504.20%
Clean Yield Group 542,342$8,937,7963.81%
MANAGED ASSET PORTFOLIOS, LLC 1,467,952$24,1923.67%
Mondrian Investment Partners LTD 4,081,715$67,266,6631.48%
Sippican Capital Advisors 82,235$1,355,2331.30%
Psagot Value Holdings Ltd. / (Israel) 174,300$2,8301.18%
Clal Insurance Enterprises Holdings Ltd 4,365,500$71,9431.08%
Legacy Wealth Asset Management, LLC 123,303$2,032,0330.73%
BRANDES INVESTMENT PARTNERS, LP 1,817,972$29,960,1750.64%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders